[Clinico-prognostic significance of plasma cortisol half-life(after intravenous administration ) during acute and chronic hepatic diseases].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 1124151)

Published in Minerva Med on March 24, 1975

Authors

S Del Prete, E Malacco, G Bonzi, A Natelli, S Roncoroni, H Jalanbo

Articles by these authors

Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy. Ann Oncol (2010) 1.79

Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol (2005) 1.37

Detection of a new serum-antigen in three epidemics of short-incubation hepatitis. Lancet (1970) 1.12

Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study. Ann Oncol (2009) 1.02

Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs). Ann Oncol (2009) 0.95

Chlorpropamide-alcohol flushing in non insulin-dependent diabetes: prevalence of small and large vessel disease and or risk factors for angiopathy. Acta Diabetol Lat (1982) 0.89

Viral hepatitis related antigens in 'autoimmune' hepatic disorders. Can Med Assoc J (1972) 0.89

Cutting the limits of aminobisphosphonates: new strategies for the potentiation of their anti-tumour effects. Curr Cancer Drug Targets (2009) 0.87

Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer. Br J Cancer (2005) 0.86

Impression cytology with scanning electron microscopy: a new method in the study of conjunctival microvilli. Eye (Lond) (2007) 0.85

Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients. Br J Cancer (2002) 0.85

Different Australia-antigen determinants in acute viral hepatitis. Lancet (1970) 0.83

Epidemic hepatitis-associated antigen. Can Med Assoc J (1972) 0.83

Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide: a single center experience. Oncol Rep (2008) 0.82

Translational and post-translational modifications of proteins as a new mechanism of action of alpha-interferon: review article. Amino Acids (2004) 0.81

A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension. J Hypertens (2001) 0.80

Anemia may influence the outcome of patients undergoing neo-adjuvant treatment of rectal cancer. Ann Oncol (2006) 0.80

Mediastinal images resembling thymus following 131-I treatment for thyroid cancer. Monaldi Arch Chest Dis (2005) 0.78

Once-per-cycle pegfilgrastim in breast cancer patients treated with docetaxel/epidoxorubicin/cyclophosphamide. Eur J Cancer Care (Engl) (2009) 0.76

Evening vs morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring. Br J Clin Pharmacol (1993) 0.76

Role of brain catecholamines in the postcastration rise in plasma LH of prepuberal rats. Endocrinology (1974) 0.76

Peripheral blood progenitor cell cycle kinetics following priming with pIXY321 in patients treated with the "ICE" regimen. Yale J Biol Med (1999) 0.75

Epidemic hepatitis-associated antigen (milan antigen). Study on normal population and sporadic acute viral hepatitis. Am J Dis Child (1972) 0.75

[Treatment of chronic portal-systemic encephalopathy with lactulose (synthetic disaccharide: one molecule of galactose and one of fructose)]. Clin Ter (1972) 0.75

[Response to phytohemagglutinin in mixed cultures of homologous, normal lymphocytes and those from patients with chronic lymphatic leukemia]. Tumori (1969) 0.75

[DA 3177 a new synthetic spasmolytic agent in the management of spastic-dyskinetic conditions of the digestive tract. Double-blind controlled clinical trial]. Clin Ter (1979) 0.75

[Complications of peridural anesthesia]. Minerva Anestesiol (1967) 0.75

[Some indications for methoxyglurane in ORL surgery]. Minerva Anestesiol (1967) 0.75

[Insulin and chondrogenesis: experimental study of chick embryo malformation]. Boll Soc Ital Biol Sper (1980) 0.75

[Relations between the levels of some proteins in the serum and interstitial fluid]. Boll Soc Ital Cardiol (1977) 0.75

[Role of alkaline phosphatase Regan isoenzyme in prognosis of patients with osteosarcoma]. Medicina (Firenze) (1991) 0.75

[Prognosis of acute hepatitis B]. Minerva Med (1979) 0.75

[Electrophoretic studies of extracts of peripheral lymphocytes and pathological lymph nodes]. Haematol Lat (1969) 0.75

[Preliminary clinical experience with a new hemostatic: dicyone]. Minerva Otorinolaringol (1969) 0.75

[CI-581 in pediatric surgery]. Minerva Anestesiol (1968) 0.75

Increased cAMP levels in human hair follicles due to local treatment with trichoriboside. Int J Tissue React (1994) 0.75

[Blastic transformation by means of phytohemagglutinin of human lymphocytes cultured in vitro in the presence of homologous plasma]. Haematol Lat (1969) 0.75

[Parenteral feeding in the newborn]. Minerva Anestesiol (1969) 0.75

[The problem of post-transfusional viral hepatitis]. Haematol Lat (1968) 0.75

[Antigens and antibodies in acute viral hepatitis caused by the B virus. Clinical significance]. Minerva Med (1979) 0.75

[Hypotensive effect of saluretics]. Clin Ter (1982) 0.75

[Prevention of renal complications by Epontol]. Minerva Anestesiol (1967) 0.75

[Blastogenetic action of the plasma of patients with sarcoidosis on homologous sarcoidotic in culture]. Policlinico Prat (1967) 0.75

[Current status of bacterial endocarditis]. G Mal Infett Parassit (1966) 0.75

[Problems in the treatment of the hypertensive diabetic patient]. Minerva Med (1987) 0.75

[Problems of anesthesia in experimental homologous transplantation of the lung]. Minerva Anestesiol (1968) 0.75

[Resuscitative treatment in acute nitrobenzol poisoning]. Minerva Anestesiol (1968) 0.75

[Plasil in the prevention and treatment of postoperative digestive complications in children]. Minerva Anestesiol (1968) 0.75

[Evaluation in cardiopathic patients of the diagnostic significance of the test of triiodothyronine inhibition of iodine uptake by the thyroid gland as a thyroid function test]. Folia Cardiol (1968) 0.75

[Clinical study of the changes in gastric secretion in children in relation to anesthesia and to the surgical operation]. Minerva Anestesiol (1967) 0.75

[Metabolic significance of NEFA (non esterified fatty acids) in plasma and their importance in emergency situations]. Minerva Anestesiol (1969) 0.75

[Catecholamines and adrenergic drugs. Pharmacodynamics and clinical aspects of anesthesiology]. Minerva Anestesiol (1968) 0.75

[Possibilities of detection of viral hepatitis in dialytic centers]. Minerva Nefrol (1971) 0.75

[Submucosal lingual administration of succinylcholine in pediatric surgery]. Minerva Anestesiol (1967) 0.75

[Evaluation of the efficacy and tolerance of doxazosin vs. enalapril inaged patients with light to moderate arterial hypertension]. Clin Ter (1995) 0.75

[Biologic aspects and clinical use of granulocyte growth factor]. Recenti Prog Med (1995) 0.75

Evidence for a role of a serum factor stimulated by metoclopramide in regulating aldosterone secretion. Biochem Biophys Res Commun (1984) 0.75

Comparison of a vasodilating beta-blocker and a cardioselective beta-blocker in long-term treatment of hypertension: a European multicentre study. J Hypertens Suppl (1989) 0.75

[Clinical applications of a new anesthetic (CI-581) in ophthalmology]. Minerva Anestesiol (1968) 0.75

[Rheomacrodex action on blood coagulation]. Minerva Anestesiol (1967) 0.75

[Hypertension therapy in the elderly. Our experience with converting enzyme inhibitors]. Minerva Med (1986) 0.75

[The combined use of alpha-methyldopa and butizide in the treatment of arterial hypertension]. Clin Ter (1981) 0.75

[Experimental study on the side effects of Epontol]. Minerva Anestesiol (1967) 0.75

[Sequelae of inadequate treatment of non-severe thoracic injuries]. Minerva Anestesiol (1968) 0.75

[Au antigen and corresponding antibodies. Comparative study of their incidence in hospital personnel and blood donors]. Minerva Med (1970) 0.75

Immunoloiical studies of a community outbreak of hepatitis. Gut (1970) 0.75

[Distribution of viral hepatitis associated antigens and antibodies in the normal population]. Boll Ist Sieroter Milan (1973) 0.75

Presymptomatic diagnosis of hepatitis. Lancet (1969) 0.75

[Post-transfusional viral hepatitis. Epidemiological study and control of polytransfused patients. Preliminary note]. Minerva Med (1968) 0.75

[Importance of the Au hepatitis antigen in the diagnosis of viral hepatitis]. Minerva Med (1969) 0.75

[Diuretic therapy in the course of hepatic cirrhosis with ascites]. Osp Maggiore (1965) 0.75

[Problems of intestinal canalization in neonatal resuscitation]. Minerva Anestesiol (1968) 0.75

Milan antigen. Lancet (1972) 0.75

[Effect of various anesthetics on the electrical activity of the hypothalamus and repercussions on the gastrointestinal system. Experimental study on cats]. Minerva Anestesiol (1968) 0.75

[Normalization of the gastrointestinal function after pediatric surgery]. Minerva Anestesiol (1968) 0.75

In vitro steroidogenic properties of FK 33 824, a stable analog of methionine-enkephalin. Opiate-dopamine interaction in the control of aldosterone production. J Endocrinol Invest (1983) 0.75

[Chronic hepatitis. New classification and clinical criteria]. Recenti Prog Med (1974) 0.75

Do the hepatitis antigens cross the placenta? Lancet (1971) 0.75

[Sensitivity of cultured human lymphocytes to nitrofurantoin]. Arch Sci Med (Torino) (1968) 0.75

[Acute and chronic cardiac decompensation: is vasodilator therapy useful?]. Minerva Med (1982) 0.75

Central hypothermia by 2-deoxy-D-glucose: antagonism by alpha-adrenergic activation. Eur J Pharmacol (1974) 0.75

[Sluder and Charlin syndrome in painful pathology of the face. Clinico-statistical contribution]. Minerva Anestesiol (1968) 0.75

[Toxicity of ketamine]. Minerva Anestesiol (1974) 0.75

[Relation between serum biliary acid and respiratory test with 14C aminopyrine in patients with hepatic cirrhosis]. Clin Ter (1985) 0.75

[Intra- and post-operative problems in a case of pneumonectomy for large broncho-pleuro-cutaneous fistula]. Minerva Anestesiol (1968) 0.75

[Current status and prospects of the control of viral hepatitis in hemodialysis centers, The Australia antigen]. Minerva Nefrol (1971) 0.75

[Evaluation of intestinal peristalsis in children]. Minerva Anestesiol (1968) 0.75

Acute and long-term haemodynamic effects of propranolol and indenolol in hypertension. Eur J Clin Pharmacol (1986) 0.75

Experiences on Australia antigen in Italy. Vox Sang (1971) 0.75

[Viral hepatitis and associated antigens]. Minerva Med (1972) 0.75